These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21643956)

  • 1. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.
    Shen W; Cao X; Xi L; Deng L
    Mol Biol Rep; 2012 Feb; 39(2):2039-44. PubMed ID: 21643956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
    Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
    Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2,931 subjects.
    Xia Y; Guo XG; Ji TX
    Asian Pac J Cancer Prev; 2014; 15(6):2857-61. PubMed ID: 24761914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.
    Zhu K; Jiang B; Hu R; Yang Y; Miao M; Li Y; Liu Z
    PLoS One; 2014; 9(9):e108953. PubMed ID: 25268356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis.
    Ma XY; Jin Y; Sun HM; Yu L; Bai J; Chen F; Fu SB
    Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1702-8. PubMed ID: 22762525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.
    Meng D; Wu YX; Heerah V; Peng S; Chu MD; Xu YJ; Xiong WN; Xu SY
    J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):319-326. PubMed ID: 26072067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.
    Kruszyna Ł; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
    DNA Cell Biol; 2010 Aug; 29(8):423-7. PubMed ID: 20406099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
    Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
    Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.
    Alijanpour A; Golshan A; Vakili-Ojarood M; Shirinzadeh-Dastgiri A; Naseri A; Karimi-Zarchi M; Hajizadeh N; Barahman M; Azizi S; Aghasipour M; Khajehnoori S; Aghili K; Neamatzadeh H
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):767-776. PubMed ID: 38546059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.
    Fang F; Yao L; Yu XJ; Yu L; Wu Q; Yu L
    Breast Cancer Res Treat; 2010 Jul; 122(1):267-71. PubMed ID: 20035378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
    Ma Y; Bian J; Cao H
    PLoS One; 2013; 8(2):e56918. PubMed ID: 23451111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
    Yu KD; Chen AX; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies.
    Moazeni-Roodi A; Ghavami S; Hashemi M
    Microrna; 2019; 8(2):94-100. PubMed ID: 30514199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of LEPR Gln223Arg polymorphism on breast cancer risk in different ethnic populations: a meta-analysis.
    He BS; Pan YQ; Zhang Y; Xu YQ; Wang SK
    Mol Biol Rep; 2012 Mar; 39(3):3117-22. PubMed ID: 21698367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
    de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
    J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in KCNJ11 (E23K, rs5219) and SDF-1β (G801A, rs1801157) genes are associated with the risk of type 2 diabetes mellitus.
    Rizvi S; Raza ST; Mahdi F; Singh SP; Rajput M; Rahman Q
    Br J Biomed Sci; 2018 Jul; 75(3):139-144. PubMed ID: 29893194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.
    Chang SF; Li SL; Yang B; Yao KM; Miao RH; Liang GF; Zhang KM
    Genet Mol Res; 2015 Dec; 14(4):17399-405. PubMed ID: 26782381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.
    Ding H; Fu Y; Chen W; Wang Z
    Breast Cancer Res Treat; 2010 Aug; 123(1):265-70. PubMed ID: 20130981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.